Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Brain Imaging01:14

Brain Imaging

488
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
488
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

279
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
279

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative MRI Uncovers Subtle Cortical Damage in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Annals of clinical and translational neurology·2026
Same author

Paramagnetic Rim Lesions and Choroid Plexus Volume at Diagnosis Are Associated With Cognitive Progression Independent of Relapse and MRI Activity in Early Relapsing-Remitting Multiple Sclerosis.

Annals of clinical and translational neurology·2026
Same author

Rethinking prognosis in multiple sclerosis: a multiaxial perspective.

Nature reviews. Neurology·2026
Same author

Structure-function multilayer network integration and cognition in multiple sclerosis.

Network neuroscience (Cambridge, Mass.)·2026
Same author

Real-world effectiveness and safety of ofatumumab in multiple sclerosis: a longitudinal study integrating clinical, cognitive, and MRI outcomes.

Therapeutic advances in neurological disorders·2026
Same author

Dynamic emotion recognition and authenticity detection in multiple sclerosis: preliminary cognitive, behavioral, and neuroimaging evidence.

Multiple sclerosis and related disorders·2026

Related Experiment Video

Updated: Nov 22, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.4K

Imaging and depression in multiple sclerosis: a historical perspective.

Fabio Giuseppe Masuccio1, Giulia Gamberini1, Massimiliano Calabrese2

  • 1Department of Rehabilitation, C.R.R.F. "Mons. L. Novarese", Loc. Trompone, Moncrivello, VC, Italy.

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|January 7, 2021
PubMed
Summary

Multiple sclerosis patients experience depression more often. Brain damage in multiple sclerosis (MS) is linked to depression, suggesting a neurobiological basis rather than just disability consequences.

Keywords:
DepressionDepressive symptomsMagnetic resonance imagingMultiple sclerosis

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.7K
Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

4.3K

Related Experiment Videos

Last Updated: Nov 22, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.4K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.7K
Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

4.3K

Area of Science:

  • Neuroscience
  • Neurology
  • Psychiatry

Background:

  • Multiple sclerosis (MS) patients have higher depression rates than the general population.
  • Depression in MS is multifactorial, involving psychosocial, genetic, immune-inflammatory, and neurological factors.
  • Brain damage unique to MS is implicated in the etiology of depression in these patients.

Purpose of the Study:

  • To provide a historical overview of the relationship between multiple sclerosis-related depression and brain damage.
  • To review magnetic resonance imaging (MRI) studies examining structural and functional brain changes in MS patients with depression.

Main Methods:

  • Systematic review of MRI studies.
  • Analysis of findings linking brain pathology in MS to depressive symptoms or diagnosis.

Main Results:

  • Evidence from MRI studies confirms a correlation between brain pathology and depression in multiple sclerosis.
  • Structural and functional brain impairments are associated with depressive symptoms.

Conclusions:

  • The review supports the hypothesis that brain damage is a significant factor in MS-related depression.
  • Depression in MS may have a neurobiological basis, potentially serving as a direct symptom of the neurological condition.